DexCom Inc (DXCM)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	3,603,200	3,380,700	3,175,600	3,001,700	2,889,200	2,740,300	2,599,600	2,478,000	2,333,800	2,206,500	2,058,200	1,914,400	1,823,900	1,754,600	1,659,800	1,555,100	1,426,800	1,302,000	1,187,500	1,108,600
Total assets	US$ in thousands	6,264,500	6,596,200	6,820,700	5,515,900	5,391,700	4,899,200	5,217,400	5,057,000	4,933,300	4,775,900	4,503,800	4,389,800	4,290,500	3,833,200	3,521,800	2,447,900	2,395,000	2,185,700	2,065,900	1,974,000
Total asset turnover		0.58	0.51	0.47	0.54	0.54	0.56	0.50	0.49	0.47	0.46	0.46	0.44	0.43	0.46	0.47	0.64	0.60	0.60	0.57	0.56

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $3,603,200K ÷ $6,264,500K
= 0.58

Dexcom Inc's total asset turnover ratio has shown some fluctuations over the past eight quarters. The ratio ranged from a low of 0.47 in Q2 2023 to a high of 0.58 in Q4 2023. Generally, a higher total asset turnover ratio indicates that the company is generating more revenue per dollar of assets.

The trend in Dexcom's total asset turnover ratio appears to be slightly unstable, with some quarters performing better than others. It is important for the company to analyze the factors affecting this ratio, such as sales growth, asset utilization efficiency, and operational effectiveness. By identifying areas for improvement, Dexcom can work towards optimizing its asset turnover and potentially enhancing its overall financial performance.